Ma and colleagues demonstrated that miR-26a and miR-26b negatively regulate ST8SIA4 via directly targeting the 3′-UTR of ST8SIA4 to inhibit migration and invasion in vitro of aggressive breast cancer cells [34]. The gene discussed is ST8SIA4; the disease is breast carcinoma.